CooperVision Expands Recall of Lenses to Include Avaira Sphere Contact Lenses

Nov. 17, 2011 - PRLog -- CooperVision Inc. issued a press release on November 15, 2011 announcing that is was adding nearly 5 million Avaira Sphere contact lenses to a recent lens recall due to the presence of silicone oil residue on the lenses, which has been linked to blurred vision, eye injuries and severe pain.  http://www.marketwire.com/press-release/coopervision-announces-expanded-recall-of-encore100-line-of-contact-lenses-1587504.htm

This expanded recall follows an October 14 U.S. Food and Drug Administration (FDA) Class I Warning issued for approximately 778,000 Avaira Toric soft contact lenses because they failed to meet quality standards due to the level of a silicone oil residue. http://www.fda.gov/MedicalDevices/Safety/RecallsCorrectionsRemovals/ListofRecalls/ucm275835.htm.  Class I recalls are the most serious type of recall and involve situations in which there is a reasonable probability that use of these products will cause serious adverse health consequences or death.  

For the Avaira Toric Lenses, consumers can visit CooperVison’s website at www.coopervision.com/recall and enter the lot number of their package to determine whether their lenses are part of the recall. The affected lenses were manufactured from November 1, 2010 through August 3, 2011.

For the Avaira Sphere Lenses, CooperVision will have a recall website launched on Friday, November 18 at www.coopervision.com/international-recall where consumers can enter the lot number of their packet to determine whether their lenses are part of the recall.  

CooperVision said no other product line uses silicone oil in the manufacturing process other than Avaira Sphere and Avaira Toric.

Ennis & Ennis, P.A. recommends consumers who have the affected lenses, but have not suffered the symptoms, should return their lenses to their eye care practitioner or point of purchase.

Furthermore, consumers who have been affected by the recall and have suffered symptoms should immediately stop wearing the lenses and immediately contact their eye care practitioner for advice.  Then they should file an adverse event report with the FDA at https://www.accessdata.fda.gov/scripts/medwatch/medwatch-....  Lastly, they should consult with an experienced attorney.

Ennis & Ennis is offering free, nationwide, confidential consultations to anyone who has suffered an eye injury as a result of the AVAIRA Toric or Sphere contact lenses by calling toll free 1-800-856-6405 or by going to www.ennislaw.com and completing an online case evaluation form.

Ennis & Ennis, P.A. is a nationwide law firm with offices in Ft. Lauderdale, Miami and Washington D.C. that concentrates its practice in mass torts and represents individuals against pharmaceutical companies as well as medical device makers.

Ennis & Ennis, P.A. has been representing clients individually since 1986 and has recovered over $100 million in settlements for its clients.

Ennis & Ennis, P.A. is also investigating cases involving, Accutane, Actos, Avandia, Fosamax, Paxil, Zoloft, Prozac, Depuy Hip Recall, Zimmer Hip Recall, Depakote, Reglan, SJS/Dilantin, Yaz, Yasmin, Ocella Birth Control Pills, and Transvaginal Mesh Devices.

Remember the law limits the time in which you can file a claim, so don't wait to explore your legal rights.  Call today toll free 1-800-856-6405 or visit www.ennislaw.com.